▪ After normalising for non recurring payments, GOCF was a $10.2m inflow (FY16: $57.6m outflow).
Remember the heavy advertising in the end of the financial year. Cash burn to make it look worse than it is?
Initial thoughts are that I smell a rat. Based on tonight I will most likely vote no to the scheme if given the opportunity. All benefits to lenders we shareholders get the risks. No thanks.
- Forums
- ASX - By Stock
- SGH
- Ann: SGH FY17 Results Presentation
Ann: SGH FY17 Results Presentation, page-22
-
-
- There are more pages in this discussion • 341 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SGH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online